Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →
Help us improve your experience. Please confirm your investor type:
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
2B78 ETF · iShares Healthcare Innovation UCITS ETF
Performance & flows
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -0.26%  | -10.50% | +14.06% | +13.09% | -19.36% | -2.46% | -2.46% | -6.59% | |
| Flows |
Key fund info
Essentials
Enterprise
Similar ETFs
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -10.50% | +14.06% | +13.09% | -19.36% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Exposure
Sustainability
ESG Consensus® by Conser
Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about 2B78 ETF's sustainability, based on their methodology.
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
2B78’s has a Final Sustainability Grade of either A+, A, or A-.
Replication
Issuer
| AuM | ||
|---|---|---|
IVV | iShares Core S&P 500 ETF | €675.72B |
IEFA | iShares Core MSCI EAFE ETF | €150.71B |
IEMG | iShares Core MSCI Emerging Markets ETF | €128.96B |
CSSPX | iShares Core S&P 500 UCITS ETF | €119.84B |
AGG | iShares Core U.S. Aggregate Bond ETF | €115.8B |
Frequently asked questions about 2B78
What does iShares Healthcare Innovation UCITS ETF, 2B78, invest in?
2B78 is a Passive ETF. This ETF provides exposure to Other Equities.
Which benchmark or index does 2B78 replicate?
2B78 tracks the STOXX Global Breakthrough Healthcare Index - USD, through a optimized sampling replication method.
What is the Total Expense ratio (TER) of 2B78?
2B78 carries a total expense ratio (TER) of 0.4%, indicating the annual cost for holding the fund.
When was 2B78 launched?
2B78 was introduced to the market on September 8, 2016. It trades on Netherlands, among other exchanges
Who is the ETF issuer of 2B78?
iShares Healthcare Innovation UCITS ETF, 2B78, is provided by iShares. Learn more about iShares here.
What is the current assets under management (AUM) of 2B78?
2B78 oversees €814M in assets as of April 29, 2026.
How has 2B78 performed lately?
Based on data from April 29, 2026, 2B78 returned -0.26% over the past month, -10.50% over the last three months and -6.59% year-to-date.
What are the latest inflows or outflows for 2B78?
As of April 29, 2026, 2B78 recorded net flows of -€11M over the last month and -€18M year-to-date.
Does 2B78 distribute dividends?
2B78 follows a capitalizing, meaning it reinvests income within the fund.
What are the main country or region exposures of 2B78?
As of March 31, 2026, 2B78 has significant geographic allocations in USA, Switzerland and Republic of Korea.
In which sector or theme does 2B78 invest in?
As of March 31, 2026, 2B78 focuses largely on Health Care and Information Technology.
How many securities does 2B78 hold and how diversified is it?
As of March 31, 2026, 2B78 holds 172 positions in its portfolio, with 30.82% of assets concentrated in its top 15 holdings.
What are the main positions in 2B78?
As of March 31, 2026, 2B78 top three holdings include MODERNA INC, UCB and JOHNSON&JOHNSON.
What is the base currency of 2B78?
The base currency of 2B78 is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
